Literature DB >> 24839155

Post-approval monitoring and oversight of U.S.-initiated human subjects research in resource-constrained countries.

Brandon Brown1, Janni Kinsler, Morenike O Folayan, Karen Allen, Carlos F Cáceres.   

Abstract

The history of human subjects research and controversial procedures in relation to it has helped form the field of bioethics. Ethically questionable elements may be identified during research design, research implementation, management at the study site, or actions by a study's investigator or other staff. Post-approval monitoring (PAM) may prevent violations from occurring or enable their identification at an early stage. In U.S.-initiated human subjects research taking place in resource-constrained countries with limited development of research regulatory structures, arranging a site visit from a U.S. research ethics committee (REC) becomes difficult, thus creating a potential barrier to regulatory oversight by the parent REC. However, this barrier may be overcome through the use of digital technologies, since much of the world has at least remote access to the Internet. Empirical research is needed to pilot test the use of these technologies for research oversight to ensure the protection of human subjects taking part in research worldwide.

Entities:  

Mesh:

Year:  2014        PMID: 24839155     DOI: 10.1007/s11673-014-9525-4

Source DB:  PubMed          Journal:  J Bioeth Inq        ISSN: 1176-7529            Impact factor:   1.352


  8 in total

1.  Involving vulnerable populations of youth in HIV prevention clinical research.

Authors:  Nicolette Borek; Susannah Allison; Carlos F Cáceres
Journal:  J Acquir Immune Defic Syndr       Date:  2010-07       Impact factor: 3.731

2.  Globalized research and "national science": the case of Peru.

Authors:  Carlos F Cáceres; Walter Mendoza
Journal:  Am J Public Health       Date:  2009-08-20       Impact factor: 9.308

3.  Ethics and clinical research.

Authors:  H K Beecher
Journal:  N Engl J Med       Date:  1966-06-16       Impact factor: 91.245

4.  US IRBs confronting research in the developing world.

Authors:  Robert L Klitzman
Journal:  Dev World Bioeth       Date:  2012-04-20       Impact factor: 2.294

5.  The Belmont Report. Ethical principles and guidelines for the protection of human subjects of research.

Authors: 
Journal:  J Am Coll Dent       Date:  2014

6.  Media reporting of tenofovir trials in Cambodia and Cameroon.

Authors:  Edward Mills; Beth Rachlis; Ping Wu; Elaine Wong; Kumanan Wilson; Sonal Singh
Journal:  BMC Int Health Hum Rights       Date:  2005-08-24

7.  Research misconduct in low- and middle-income countries.

Authors:  Joseph Ana; Tracey Koehlmoos; Richard Smith; Lijing L Yan
Journal:  PLoS Med       Date:  2013-03-26       Impact factor: 11.069

8.  Policies and initiatives aimed at addressing research misconduct in high-income countries.

Authors:  David B Resnik; Zubin Master
Journal:  PLoS Med       Date:  2013-03-26       Impact factor: 11.069

  8 in total
  3 in total

1.  "Can a Company be Bitchy?" Corporate (and Political and Scientific) Social Responsibility.

Authors:  Leigh E Rich; Michael A Ashby
Journal:  J Bioeth Inq       Date:  2015-05-28       Impact factor: 1.352

2.  Consent Requirements for Testing Health Policies: An Intercontinental Comparison of Expert Opinions.

Authors:  Astrid Berner-Rodoreda; Shannon McMahon; Nir Eyal; Puspita Hossain; Atonu Rabbani; Mrittika Barua; Malabika Sarker; Emmy Metta; Elia Mmbaga; Melkizedeck Leshabari; Daniel Wikler; Till Bärnighausen
Journal:  J Empir Res Hum Res Ethics       Date:  2022-02-10       Impact factor: 1.978

3.  Stakeholders' engagement with Ebola therapy research in resource limited settings.

Authors:  Morenike Oluwatoyin Folayan; Brandon Brown; Bridget Haire; Aminu Yakubu; Kristin Peterson; Jemee Tegli
Journal:  BMC Infect Dis       Date:  2015-06-26       Impact factor: 3.090

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.